Human papillomavirus and cervical disease in adolescents.
The addition of the human papillomavirus vaccination and the 2006 national guidelines for the management of abnormal cervical cytology have led to significant changes in the management of cervical disease among adolescents. This article reviews recommendations for prevention, screening, diagnosis, and management of cervical disease.
Guido
Richard
R
Magee Women's Hospital, Pittsburgh, Pennsylvania, USA. rguido@mail.magee.edu
D000293:Adolescent; D003127:Colposcopy; D005260:Female; D006801:Humans; D008403:Mass Screening; D027383:Papillomaviridae / Q000302:isolation & purification; D030361:Papillomavirus Infections / Q000175:diagnosis* / Q000517:prevention & control / Q000821:virology; D053918:Papillomavirus Vaccines; D011230:Precancerous Conditions; D014412:Tumor Virus Infections / Q000175:diagnosis* / Q000517:prevention & control / Q000821:virology; D002577:Uterine Cervical Diseases / Q000175:diagnosis* / Q000517:prevention & control / Q000821:virology; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000517:prevention & control / Q000821:virology; D014626:Vaginal Smears
D053918:Papillomavirus Vaccines